Focus on improving our planet.
Let's collaborate for sustainability &
digitalization.

Open innovation Platform for sustainability.
Find the right opportuinty and grow up your
innovation ecosystem.

Sign in/up

Search an
opportunity

Do you want to be part of innovative a sustainable project? Search for your opportunity and make your contribution to for the sustainable growth of the economy and the planet.

Tech collaborations
Joint Ventures
Licensing
Subcontracting
Investment

Express interest
Biomarkers for the diagnosis of pediatric B-cell acute lymph...
created · Updated
Deadline: Aug 4, 2022
Received 0 expressions of interest

Summary

A Spanish university has developed two new biomarkers for the diagnosis of pediatric B-cell acute lymphoblastic leukemia. The technology makes it possible to recognize and evaluate patients who develop the disease and thus supports in therapeutic decision-making. The university is looking for partners interested in licensing this patented technology.

Description

Pediatric B-cell acute lymphoblastic leukemia (B-ALL) is the most common childhood malignancy that, characterized by its heterogeneity and aggressiveness, requires new targeted therapies. In recent years, this search has focused on the identification of non-coding Ribonucleic acid (ncRNA), crucial regulators of gene expression. Dysregulation of these long ncRNAs (lncRNAs) has been linked to numerous human diseases and is also associated with oncogenic or tumor suppressor phenotypes.

Given the absence of a clinically relevant lncRNA consensus signature for pediatric B-ALL, researchers at a Spanish University have studied the lncRNA profiles of pediatric patients with this lymphoma, identifying two new biomarkers for the diagnosis, prognosis, prevention, improvement or alleviation in the treatment.

This invention provides the use of lncRNA and mRNA as diagnostic biomarkers, whose method consists in the quantification of their expression levels from an isolated sample of the bone marrow of the individual. In this way, by comparing the amounts expressed, it is possible to obtain useful data for the diagnosis of pediatric B-ALL, facilitating therapeutic decision-making in these patients.

The university is looking for partners from pharmaceutical or biotechnology / health related companies interested in licensing this patented technology.

Advantages & innovations

• Diagnostic biomarkers of pediatric B-cell acute lymphoblastic leukemia that allows the evaluation and identification of individuals with the disease. • Support in the therapeutic strategy of patients with pediatric B-cell acute lymphoblastic leukemia: The use of these biomarkers could be used in therapeutic decision-making for patients with the desease. • No specific equipment is required. Quantification of biomarker expression can be carried out using a variety of currently popular techniques, generally common and accessible in laboratories in the field such as Reverse transcription polymerase chain reaction (RT-PCR), among others). • Simple method. The possibility of using a kit or device makes it easier to obtain useful data for the diagnosis and prognosis of this type of leukemia.

Stage of development

Under development/lab tested

Partner sought

The university is looking for partners from biotech / health / pharma related companies with experience in the use of biomarkers and/or pediatric ALL-B diagnosis, interested in licensing this technology.

Create an
opportunity

Show your project-opportunity to generate interest of potential partners or collaborators. Companies, freelancers, or research centers can meet in Nir-vana and become perfect team together!

Latest Opportunities

EIT Food Public Engagement Proof of Concepts Call for Proposals 2023,...

published
Deadline: Aug 15, 2024
Project full name: EIT Food Public Engagement Proof of Concepts Call for Proposals 2023, 2024, 2025
Project acronym: EIT Food PE PoC Call 2023, 2024, 2025
Grant agreement number: N/A
Total EU funding available: €360 000 per submission window (total for 3 rounds: €1 380 000)
By the date of the Calls’ launches a webpage will be activated at eitfood.eu/projects/public-engagement-proof-of-concepts-call

Join and create
your ecosystem

Meet and connect with experts from around the world. Generate your innovative ecosystem and interact with them thanks to the different functionalities of Nir-vana: exchange spaces, lists of opportunities, expression of interest

Karoly Nagy
Jordi Hurtado
Build your project with
the best professionals
in the sector
Latest Opportunities

    EIT Food Public Engagement Proof of Concepts Call for Proposals 2023,...

    published
    Deadline: Aug 15, 2024
    Project full name: EIT Food Public Engagement Proof of Concepts Call for Proposals 2023, 2024, 2025
    Project acronym: EIT Food PE PoC Call 2023, 2024, 2025
    Grant agreement number: N/A
    Total EU funding available: €360 000 per submission window (total for 3 rounds: €1 380 000)
    By the date of the Calls’ launches a webpage will be activated at eitfood.eu/projects/public-engagement-proof-of-concepts-call
    Swedish SME in the hygiene sector produces washable re-usable absorbent underwear helping people with little leaks such as incontinence (urine escape due to bladder weakness) or other forms of leakage during periods or pregnancy. Compared to disposable products they are environmentally sustainable, less costly, providing a sense of normalisation and comfort for users. The SME is looking for sales agents, retailers, distributors interested in entering business collaboration agreements
    Company based in Sweden, is a pioneering force in digital cleaning training, specializing in e-learning for cleaners, supervisors, and clients. With a proven track record since 1994 and a recent foray into international markets, companyseeks strategic partnerships in Europe.
    Spanish company manufacturing vinegars, lemon juice, food dressings, balsamic creams and other related products in different types of containers and different formats and weights, is looking for wholesaler or distributor. Preferred channels: supermarkets, large distribution, convenience stores, hospitality services (hotels, restaurants and catering), gourmet shops and others.

The most relevant open & connected
network for sustainable business development.

Join now!

Sustainable
projects

Nir-vana wants to be the first open innovation platform focus on sustainability.

According to the EU Action Plan there is a huge need of change to a more sustainable future and to collaborate and assure to achieve the SDG.

Network
& experts

Nir-vana is the only platform integrating seamless "search and find" to the next stage of collaborating.

Get connected with experts and companies for partnering. Find trusted innovation advisors, certified by Enterprise Europe Network and build up your team of partners, companies and experts you need for your innovation.

Find public funding &
private investors

Discover potential funding opportunities for your innovation. On nir-vana you have access to national and EU funding programmes, public funding and private investors.

Get connected to consultants and advisors specialised on funding and grant preparation.